Advances in the clinical laboratory assessment of urinary sediment

Clinica Chimica Acta

Volumn 340, Issue 1-2, 2004, Pages 67-78

  Chan, Rebecca Wing Yan ^a   Szeto, Cheuk Chun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Flow cytometry; Kidney; Urinalysis; Urology

Indexed keywords

CD16 ANTIGEN; CYTOKERATIN 20; CYTOKINE; DNA; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ACUTE GRAFT REJECTION; AUTOANALYZER; BLADDER CANCER; CANCER DIAGNOSIS; CANCER GENETICS; CANCER SCREENING; CELL INFILTRATION; CENTRIFUGATION; CHROMOSOME REARRANGEMENT; CLINICAL PRACTICE; DIABETIC NEPHROPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DNA DETERMINATION; EARLY DIAGNOSIS; ENZYME IMMUNOASSAY; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOGLOBULIN A NEPHROPATHY; INFLAMMATORY CELL; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LABORATORY TEST; LEUKOCYTE COUNT; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE; MACROPHAGE; MICROSATELLITE INSTABILITY; MICROSCOPY; MONOCYTE; NON INVASIVE MEASUREMENT; PATIENT MONITORING; PHENOTYPE; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA ANALYSIS; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; URINALYSIS; URINARY TRACT DISEASE; URINE CYTOLOGY;

EID: 0842346197     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.11.006     Document Type: Review

References (103)

1. Fogazzi G.B., Cameron J.S., Ritz E., Ponticelli C. The history of urinary microscopy to the end of the 19th century. Am. J. Nephrol. 14:1994;452-457.
2. Becker G.J., Fairley K.F. Urinalysis. Massry S.G., Glassock R.J. Textbook of nephrology. 4th ed. 2001;1765-1783 Lippincott Williams and Wilkins, Philadelphia.
3. Sherman A.B., Koss L.G., Adams S.E. Interobserver and intraobserver differences in the diagnosis of urothelial cells. Comparison with classification by computer. Anal. Quant. Cytol. 6:1984;112-120.
4. Canaris G.J., Flach S.D., Tape T.G., Stierwalt K.M., Haggstrom D.A., Wigton R.S. Can internal medicine residents master microscopic urinalysis? Results of an evaluation and teaching intervention. Acad. Med. 78:2003;525-529.
5. Wigton R.S., Blank L.L., Nicolas J.A., Tape T.G. Procedural skills training in internal medicine residencies. A survey of program directors. Ann. Intern. Med. 111:1989;932-938.
6. Hilborne L.H., Wenger N.S., Oye R.K. Physician performance of laboratory tests in self-service facilities. Residents' perceptions and performance. JAMA. 264:1990;382-386.
7. Phillips C., Henderson P.J., Mandel L., Kim S., Schaad D., Cooper M.et al. Teaching the microscopic examination of urine sediment to second year medical students using the Urinalysis-Tutor computer program. Clin. Chem. 44:1998;1692-1700.
8. Lakatos J., Bodor T., Zidarics Z., Nagy J. Data processing of digital recordings of microscopic examination of urinary sediment. Clin. Chim. Acta. 297:2000;225-237.
9. Hannemann-Pohl K., Kampf S.C. Automation of urine sediment examination: a comparison of the Sysmex UF-100 automated flow cytometer with routine manual diagnosis (microscopy, test strips, and bacterial culture). Clin. Chem. Lab. Med. 37:1999;753-764.
10. Yasui Y., Tatsumi N., Koezuka T., Okamura M., Yamagami S. Comparison of three methods for analysis of urinary sediments. Osaka City Med. J. 42:1996;77-92.
11. Fenili D., Pirovano B. The automation of sediment urinalysis using a new urine flow cytometer (UF-100). Clin. Chem. Lab. Med. 36:1998;909-917.
12. Delanghe J.R., Kouri T.T., Huber A.R., Hannemann-Pohl K., Guder W.G., Lun A.et al. The role of automated urine particle flow cytometry in clinical practice. Clin. Chim. Acta. 301(1-2):2000 (Nov.);1-18. [Review].
13. Langlois M.R., Delanghe J.R., Steyaert S.R., Everaert K.C., De Buyzere M.L. RAutomated flow cytometry compared with an automated dipstick reader for urinalysis. Clin. Chem. 45(1):1999 (Jan.);118-122.
14. Ben-Ezra J., Bork L., McPherson R.A. Evaluation of the Sysmex UF-100 automated urinalysis analyzer. Clin. Chem. 44(1):1998 (Jan.);92-95.
15. Kouri T.T., Kahkonen U., Malminiemi K., Vuento R., Rowan R.M. Evaluation of Sysmex UF-100 urine flow cytometer vs chamber counting of supravitally stained specimens and conventional bacterial cultures. Am. J. Clin. Pathol. 112(1):1999 (Jul.);25-35.
16. Regeniter A., Haenni V., Risch L., Kochli H.P., Colombo J.P., Frei R.et al. Urine analysis performed by flow cytometry: reference range determination and comparison to morphological findings, dipstick chemistry and bacterial culture results - a multicenter study. Clin. Nephrol. 55(5):2001 (May);384-392.
17. Roggeman S., Zaman Z. Safely reducing manual urine microscopy analyses by combining urine flow cytometer and strip results. Am. J. Clin. Pathol. 116(6):2001 (Dec.);872-878.
18. Koken T., Aktepe O.C., Serteser M., Samli M., Kahraman A., Dogan N. Determination of cut-off values for leucocytes and bacteria for urine flow cytometer (UF-100) in urinary tract infections. Int. Urol. Nephrol. 34(2):2002;175-178.
19. Manoni F., Valverde S., Antico F., Salvadego M.M., Giacomini A., Gessoni G. Field evaluation of a second-generation cytometer UF-100 in diagnosis of acute urinary tract infections in adult patients. Clin. Microbiol. Infect. 8(10):2002 (Oct.);662-668.
20. Lun A., Ziebig R., Priem F., Filler G., Sinha P. Routine workflow for use of urine strips and urine flow cytometer UF-100 in the hospital laboratory. Clin. Chem. 45(8 Pt 1):1999 (Aug.);1305-1307.
21. Hyodo T., Kumano K., Haga M., Sakai T. Detection of glomerular and non-glomerular red blood cells by automated urinary sediment analyzer. Jpn. J. Nephrol. 37:1995;35-43.
22. Fogazzi G.B., Grignani S., Colucci P. Urinary microscopy as seen by nephrologists. Clin. Chem. Lab. Med. 36:1998;919-924.
23. Hotta O., Yusa N., Ooyama M., Unno K., Furuta T., Taguma Y. Detection of urinary macrophages expressing the CD16 (Fc gamma RIII) molecule: a novel marker of acute inflammatory glomerular injury. Kidney Int. 55:1999;1927-1934.
24. Apeland T., Mestad O., Hetland O. Assessment of haematuria: automated urine flowmetry vs microscopy. Nephrol. Dial. Transplant. 16(8):2001 (Aug.);1615-1619.
25. Roberti I., Panico M., Reisman L. Urine flow cytometry as a tool to differentiate acute allograft rejection from other causes of acute renal graft dysfunction. Transplantation. 64:1997;731-734.
26. Roberti I., Panico M., Reisman L. Urine flow cytometry as a predictor of renal allograft function. Transplantation. 63:1997;781-782.
27. Roberti I., Reisman L. Serial evaluation of cell surface markers for immune activation after acute renal allograft rejection by urine flow cytometry-correlation with clinical outcome. Transplantation. 71:2001;1317-1320.
28. Krishna G.G., Fellner S.K. Lymphocyturia: an important diagnostic and prognostic marker in renal allograft rejection. Am. J. Nephrol. 2:1982;185-188.
29. Anderson J.B., Nobbs G.L., Hammonds J.C. Urinary cytology and the early detection of renal allograft rejection. J. Urol. 136:1986;10-12.
30. Segasothy M., Birch D.F., Fairley K.F., Kincaid-Smith P. Urine cytologic profile in renal allograft recipients determined by monoclonal antibodies. Transplantation. 47:1989;482-487.
31. Roberti I., Reisman L., Burrows L., Lieberman K.V. Urine cytology and urine flow cytometry in renal transplantation - a prospective double blind study. Transplantation. 59:1995;495-500.
32. Grunewald R.W., Fiedler G.M., Stock B., Grunewald J.M., Muller G.A. Immunocytological determination of lymphocytes and monocytes/macrophages in urinary sediments of renal allograft recipients. Nephrol. Dial. Transplant. 15:2000;888-892.
33. Golijanin D., Shapiro A., Pode D. Immunostaining of cytokeratin 20 in cells from voided urine for detection of bladder cancer. J. Urol. 164:2000;1922-1925.
34. Sagerman P.M., Saigo P.E., Sheinfeld J., Charitonowics E., Cordon-Cardo C. Enhanced detection of bladder cancer in urine cytology with Lewis X, M344 and 19A211 antigens. Acta Cytol. 38:1994;517-523.
35. Koss L.G., Eppich E.M., Melder K.H., Wersto R. DNA cytophotometry of voided urine sediment. Comparison with results of cytologic diagnosis and image analysis. Anal. Quant. Cytol. Histol. 9:1987;398-404.
36. Yokota M., Tatsumi N., Tsuda I., Takubo T., Hiyoshi M. DNA extraction from human urinary sediment. J. Clin. Lab. Anal. 12:1998;88-91.
37. Friedrich M.G., Erbersdobler A., Schwaibold H., Conrad S., Huland E., Huland H. Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer. J. Urol. 163:2000;1039-1042.
38. Sachs M.D., Schlechte H., Lenk V.S., Brenner S., Schnorr D., Fleige B.et al. RGenetic analysis of Tp53 from urine sediment as a tool for diagnosing recurrence and residual of bladder carcinoma. Eur. Urol. 38:2000;426-433.
39. Komeda H., Deguchi T., Yamamoto H., Iwata H., Ito Y., Saito A.et al. Detection of Neisseria gonorrhoeae in first-voided urine sediments from male urethritis patients by polymerase chain reaction. Kansenshogaku Zasshi. 66:1992;1209-1212.
40. Gaete M.V., Prado V.E., Altamirano P.D., Martinez J.B., Urrejola P., Pinto J.M. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae in Chilean asymptomatic adolescent males determined by urine sample. Sex Transm. Infect. 75(1):1999 (Feb.);67-68.
41. Leslie D.E., Azzato F., Ryan N., Fyfe J. An assessment of the Roche Amplicor Chlamydia trachomatis/Neisseria gonorrhoeae multiplex PCR assay in routine diagnostic use on a variety of specimen types. Commun. Dis. Intell. 27(3):2003;373-379.
42. Komeda H., Deguchi T., Tada K., Yamamoto H., Kanematsu E., Iwata H.et al. Comparison of polymerase chain reaction and IDEIA Chlamydia in detection of Chlamydia trachomatis from first-voided urine of male urethritis patients. Kansenshogaku Zasshi. 66(10):1992 (Oct.);1473-1478.
43. George J.A., Panchatcharam T.S., Paramasivam R., Balasubramanian S., Chakrapani V., Murugan G. Evaluation of diagnostic efficacy of PCR methods for Chlamydia trachomatis infection in genital and urine specimens of symptomatic men and women in India. Jpn. J. Infect. Dis. 56(3):2003 (Jun.);88-92.
44. Sugunendran H., Birley H.D., Mallinson H., Abbott M., Tong C.Y. Comparison of urine, first and second endourethral swabs for PCR based detection of genital Chlamydia trachomatis infection in male patients. Sex Transm. Infect. 77(6):2001 (Dec.);423-426.
45. Wilcox M.H., Reynolds M.T., Hoy C.M., Brayson J. Combined cervical swab and urine specimens for PCR diagnosis of genital Chlamydia trachomatis infection. Sex Transm. Infect. 76(3):2000 (Jun.);177-178.
46. Rietmeijer C.A., Yamaguchi K.J., Ortiz C.G., Montstream S.A., LeRoux T., Ehret J.M.et al. Feasibility and yield of screening urine for Chlamydia trachomatis by polymerase chain reaction among high-risk male youth in field-based and other nonclinic settings. A new strategy for sexually transmitted disease control. Sex Transm. Dis. 24(7):1997 (Aug.);429-435.
47. Paukku M., Puolakkainen M., Apter D., Hirvonen S., Paavonen J. First-void urine testing for Chlamydia trachomatis by polymerase chain reaction in asymptomatic women. Sex Transm. Dis. 24(6):1997 (Jul.);343-346.
48. Stary A., Tomazic-Allen S., Choueiri B., Burczak J., Steyrer K., Lee H. Comparison of DNA amplification methods for the detection of Chlamydia trachomatis in first-void urine from asymptomatic military recruits. Sex Transm. Dis. 23(2):1996 (Mar.-Apr.);97-102.
49. Tchoudomirova K., Nuhov P., Tchapanova A. Prevalence, epidemiological and clinical correlates of genital Chlamydia trachomatis infection. J. Eur. Acad. Dermatol. Venereol. 11(3):1998 (Nov.);214-220.
50. Masutomi K., Yu E.Y., Khurts S., Ben-Porath I., Currier J.L., Metz G.B. et al. Telomerase maintains telomere structure in normal human cells. Cell. 114:2003;241-253.
51. Orlando C., Gelmini S., Selli C., Pazzagli M. Telomerase in urological malignancy. J. Urol. 166(2):2001 (Aug.);666-673. [Review].
52. Muller M. Telomerase: its clinical relevance in the diagnosis of bladder cancer. Oncogene. 21:2002;650-655.
53. Erdem E., Dikmen G., Atsu N., Dogan P., Ozen H. Telomerase activity in diagnosis of bladder cancer. Scand. J. Urol. Nephrol. 37:2003;205-209.
54. Droller M.J., Kavaler E., Landman J., Liu B.C. Urinary telomerase and its possible role as a marker for bladder cancer. Keio J. Med. 47:1998;135-141.
55. Fedriga R., Gunelli R., Nanni O., Bacci F., Amadori D., Calistri D. Telomerase activity detected by quantitative assay in bladder carcinoma and exfoliated cells in urine. Neoplasia. 3:2001;446-450.
56. Yoshida K., Sugino T., Tahara H., Woodman A., Bolodeoku J., Nargund V.et al. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer. 79:1997;362-369.
57. Kinoshita H., Ogawa O., Kakehi Y., Mishina M., Mitsumori K., Itoh N.et al. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. J. Natl. Cancer Inst. 89:1997;724-730.
58. Kavaler E., Landman J., Chang Y., Droller M.J., Liu B.C. Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity. Cancer. 82:1998;708-714.
59. Eshleman J.R., Markowitz S.D. Microsatellite instability in inherited and sporadic neoplasms. Curr. Opin. Oncol. 7:1995;83-89.
60. Mao L. Microsatellite analysis. Applications and pitfalls. Ann. N. Y. Acad. Sci. 906:2000 (Apr.);55-62. [Review].
61. Gonzalez-Zulueta M., Ruppert J.M., Tokino K., Tsai Y.C., Spruck C.H. III, Miyao N.et al. Microsatellite instability in bladder cancer. Cancer Res. 53:1993;5620-5623.
62. Mao L., Schoenberg M.P., Scicchitano M., Erozan Y.S., Merlo A., Schwab D.et al. Molecular detection of primary bladder cancer by microsatellite analysis. Science. 271:1996;659-662.
63. Mao L., Lee D.J., Tockman M.S., Erozan Y.S., Askin F., Sidransky D. Microsatellite alterations as clonal markers for the detection of human cancer. Proc. Natl. Acad. Sci. U. S. A. 91:1994;9871-9875.
64. Mao L., Schoenberg M.P., Scicchitano M., Erozan Y.S., Merlo A., Schwab D.et al. Molecular detection of primary bladder cancer by microsatellite analysis. Science. 271:1996;659-662.
65. Steiner G., Schoenberg M.P., Linn J.F., Mao L., Sidransky D. Detection of bladder cancer recurrence by microsatellite analysis of urine. Nat. Med. 3:1997;621-624.
66. Schneider A., Borgnat S., Lang H., Regine O., Lindner V., Kassem M.et al. Evaluation of microsatellite analysis in urine sediment for diagnosis of bladder cancer. Cancer Res. 60:2000;4617-4622.
67. Utting M., Werner W., Dahse R., Schubert J., Junker K. Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients: a minimally invasive method for the detection of bladder cancer. Clin. Cancer Res. 8:2002;35-40.
68. Utting M., Werner W., Muller G., Schubert J., Junker K. A possible noninvasive method for the detection of bladder cancer in patients: microsatellite analysis of free DNA in urine and blood. Ann. N. Y. Acad. Sci. 945:2001;31-35.
69. van Rhijn B. W., Lurkin I., Kirkels W.J., van der Kwast T.H., Zwarthoff E.C. Microsatellite analysis-DNA test in urine competes with cystoscopy in follow-up of superficial bladder carcinoma: a phase II trial. Cancer. 92:2001;768-775.
70. Christensen M., Wolf H., Orntoft T.F. Microsatellite alterations in urinary sediments from patients with cystitis and bladder cancer. Int. J. Cancer. 85:2000;614-617.
71. Murakami K., Takemura T., Hino S., Yoshioka K. Urinary transforming growth factor-beta in patients with glomerular diseases. Pediatr. Nephrol. 11:1997;334-336.
72. Goumenos D.S., Tsakas S., El Nahas A.M., Alexandri S., Oldroyd S., Kalliakmani P.et al. Transforming growth factor-beta(1) in the kidney and urine of patients with glomerular disease and proteinuria. Nephrol. Dial. Transplant. 17:2002;2145-2152.
73. Haramaki R., Tamaki K., Fujisawa M., Ikedo H., Haramaki N., Okuda S. Steroid therapy and urinary transforming growth factor-beta1 in IgA nephropathy. Am. J. Kidney Dis. 38:2001;1191-1198.
74. Sato H., Iwano M., Akai Y., Kurioka H., Kubo A., Yamaguchi T.et al. Increased excretion of urinary transforming growth factor beta 1 in patients with diabetic nephropathy. Am. J. Nephrol. 18:1998;490-494.
75. Honkanen E., Teppo A.M., Tornroth T., Groop P.H., Gronhagen-Riska C. Urinary transforming growth factor-beta 1 in membranous glomerulonephritis. Nephrol. Dial. Transplant. 12:1997;2562-2568.
76. Kanai H., Mitsuhashi H., Ono K., Yano S., Naruse T. Increased excretion of urinary transforming growth factor beta in patients with focal glomerular sclerosis. Nephron. 66:1994;391-395.
77. Gesualdo L., Grandaliano G., Ranieri E., Monno R., Montinaro V., Manno C.et al. Monocyte recruitment in cryoglobulinemic membranoproliferative glomerulonephritis: a pathogenetic role for monocyte chemotactic peptide-1. Kidney Int. 51:1997;155-163.
78. Wada T., Furuichi K., Segawa-Takaeda C., Shimizu M., Sakai N., Takeda S.I.et al. MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis. Kidney Int. 56:1999;995-1003.
79. Grandaliano G., Gesualdo L., Ranieri E., Monno R., Stallone G., Schena F.P. Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection. Transplantation. 63:1997;414-420.
80. Saitoh A., Suzuki Y., Takeda M., Kubota K., Itoh K., Tomino Y. Urinary levels of monocyte chemoattractant protein (MCP)-1 and disease activity in patients with IgA nephropathy. J. Clin. Lab. Anal. 12:1998;1-5.
81. Wada T., Furuichi K., Sakai N., Iwata Y., Yoshimoto K., Shimizu M.et al. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int. 58:2000;1492-1499.
82. Morii T., Fujita H., Narita T., Shimotomai T., Fujishima H., Yoshioka N.et al. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy. J. Diabetes Complications. 17:2003;11-15.
83. Wang Y., Chen J., Chen L., Tay Y.C., Rangan G.K., Harris D.C. Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J. Am. Soc. Nephrol. 8:1997;1537-1545.
84. Wenzel U.O., Abboud H.E. Chemokines and renal disease. Am. J. Kidney Dis. 26:1995;982-994.
85. Neilson E.G., Couser W.G. Immunologic renal diseases. 2nd ed. 2001;Liincott Willams and Wilkins.
86. Dean G.S., Tyrrel-Price J., Crawley E., Isenberg D.A. Cytokines and systemic lupus erythematosus. Ann. Rheum. Dis. 59:2000;243-251.
87. Li B., Hartono C., Ding R., Sharma V.K., Ramaswamy R., Qian B.et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N. Engl. J. Med. 344:2001;947-954.
88. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:2001;2002-2007.
89. Li B., Hartono C., Ding R., Sharma V.K., Kracker D., Dadhania D.et al. Renal allograft surveillance by mRNA profiling of urinary cells. Transplant Proc. 33:2001;3280-3282.
90. Ding R., Medeiros M., Dadhania D., Muthukumar T., Kracker D., Kong J.M. et al. Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine. Transplantation. 74:2002;987-994.
91. Ding R., Li B., Muthukumar T., Dadhania D., Medeiros M., Hartono C.et al. CD103 mRNA levels in urinary cells predict acute rejection of renal allografts. Transplantation. 75:2003;1307-1312.
92. Muthukumar T., Ding R., Dadhania D., Medeiros M., Li B., Sharma V.K.et al. Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts. Transplantation. 75:2003;1565-1570.
93. Dadhania D., Muthukumar T., Ding R., Li B., Hartono C., Serur D.et al. Molecular signatures of urinary cells distinguish acute rejection of renal allografts from urinary tract infection. Transplantation. 75:2003;1752-1754.
94. Chan R.W., Tam L.S., Li E.K., Lai F.M., Chow K.M., Lai K.B.et al. Inflammatory cytokine gene expression in the urinary sediment of patients with lupus nephritis. Arthritis Rheum. 48:2003;1326-1331.
95. Noble A. Molecular signals and genetic reprogramming in peripheral T-cell differentiation. Immunology. 101:2000;289-299.
96. Rao A., Avni O. Molecular aspects of T-cell differentiation. Br. Med. Bull. 56:2000;969-984.
97. Farrar J.D., Asnagli H., Murphy K.M. T helper subset development: roles of instruction, selection, and transcription. J. Clin. Invest. 109:2002;431-435.
98. Glimcher L.H. Lineage commitment in lymphocytes: controlling the immune response. J. Clin. Invest. 108:2001;25-30.
99. Mullen A.C., High F.A., Hutchins A.S., Lee H.W., Villarino A.V., Livingston D.M.et al. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science. 292:2001;1907-1910.
100. Szabo S.J., Sullivan B.M., Stemmann C., Satoskar A.R., Sleckman B.P., Glimcher L.H. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science. 295:2002;338-342.
101. Lantelme E., Mantovani S., Palermo B., Campanelli R., Sallusto F., Giachino C. Kinetics of GATA-3 gene expression in early polarizing and committed human T cells. Immunology. 102:2001;123-130.
102. Lee H.J., Takemoto N., Kurata H., Kamogawa Y., Miyatake S., O'Garra A.et al. GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells. J. Exp. Med. 192:2000;105-115.
103. Klein A., Zemer R., Buchumensky V., Klaper R., Nissenkorn I. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma. Cancer. 82:1998;349-354.